Physician

Robert James Larke, M.D.

According to 2025 Medicare claims, Robert Larke, M.D. (NPI: 1881919744) practices urology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is TRI STATE UROLOGIC SERVICES PSC INC (NPI: 1275726580; TIN: 611257391) and primary practice location at 41017-5460. Larke is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Larke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 563 traditional Medicare patients, billed 18,530 HCPCS/CPT codes, and received $437,075 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,553 prescription claims across 437 beneficiaries totaling $5,838,249 in drug costs, led by Xtandi (Enzalutamide). DME data shows 123 claims. Open Payments data shows 118 records totaling $3,185. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $35,416 to $437,075. Similarly, Part D prescription costs have moved sharply higher in recent years, from $222 to $5,838,249. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $52 and ending at $379.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	160	1,040	$35,416
2017	620	9,070	$204,676
2018	566	8,370	$184,682
2019	673	11,423	$243,498
2020	642	13,136	$279,994
2021	563	12,010	$258,008
2022	574	13,127	$287,466
2023	608	13,252	$357,063
2024	563	18,530	$437,075

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	13	26	$222
2016	55	88	$1,277
2017	235	809	$23,537
2018	274	958	$47,274
2019	387	1,283	$186,657
2020	403	1,550	$1,213,509
2021	368	1,725	$2,228,215
2022	369	1,731	$2,516,720
2023	410	2,134	$4,761,262
2024	437	2,553	$5,838,249

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	68	128	$1,377
2018	N/R	48	$3,051
2019	35	155	$16,235
2020	112	391	$44,321
2021	83	293	$38,601
2022	89	276	$32,251
2023	64	209	$41,248
2024	N/R	123	$42,984

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	372	693	$88
84153	Psa (prostate specific antigen) measurement, total	221	393	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	380	589	$11
36415	Insertion of needle into vein for collection of blood sample	177	339	$9
81002	Urinalysis, manual test	397	720	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	213	6,390	$2,790,284
Nubeqa	Darolutamide	75	2,250	$956,448
Abiraterone Acetate	Abiraterone Acetate	346	10,740	$814,712
Erleada	Apalutamide	34	1,020	$425,854
Orgovyx	Relugolix	117	3,494	$311,997

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	27	$20,319
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	59	$11,613
A4353	Intermittent urinary catheter, with insertion supplies	N	N/R	12	$10,698
A4332	Lubricant, individual sterile packet, each	N	N/R	25	$354

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	118	$3,185	Calyxo, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert James Larke, M.D.?

Tedicare shows public-source Medicare data for Robert James Larke, M.D. (NPI 1881919744), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert James Larke, M.D. have ACO affiliation data?

Robert James Larke, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Robert James Larke, M.D.?

Robert James Larke, M.D. is linked to TRI STATE UROLOGIC SERVICES PSC INC (billing NPI 1275726580) in the available physician profile data.

Does Robert James Larke, M.D. have Open Payments data?

Robert James Larke, M.D. has 118 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.